Vidarabine structure
Vidarabine
Vidarabine is an antiviral drug which is active against herpes simplex and varicella zoster viruses.Target: DNA/RNA SynthesisVidarabine is a nucleoside antibiotic isolated from Streptomyces antibioticus. It has some antineoplastic properties and has broad spectrum activity against DNA viruses in cell cultures and significant antiviral activity against infections caused by a variety of viruses such as the herpes viruses, the vaccinia VIRUS and varicella zoster virus [1].
Find 4 Related Holders
Prime European Therapeuticals S.p.A. (Euticals S.p.A.)
Japan
Japan
API Registration Country
API Active
-
Country:
Japan -
Email:
Guangdong Xiangxue Pharmaceutical Co., Ltd.
China
China
API Registration Country
API Active
-
Founded in:
2011-09-06 -
Country:
China -
Address:
No. 2, Jinfengyuan Road, Science City, Huangpu District, Guangzhou (the fourth building) -
Tax NO.:
91441600581445197U -
Registered Funds:
70 million yuan -
Email:
PFANSTIEHL LABORATORIES INC
United States
United States
API Registration Country
API Inactive
-
Country:
United States -
Email:
PHARMACIA AND UPJOHN AB
Belgium
Belgium
API Registration Country
API Inactive
-
Founded in:
1998-07-16 00:00:00 -
Country:
Belgium -
Address:
Lindhagensgatan 133, Stockholm, Zweden -
Email:
Recommended Suppliers of Vidarabine
-
Wuhan Oner Biotech Co.,Ltd.
CN1 YR
Contact Supplier -
Henan Lihao Chem Plant Limited
CN1 YR
Contact Supplier -
Xinxiang Aurora Biotechnology Co.,Ltd
CN1 YR
Contact Supplier -
Yangzhou Juhechang Technology Co., Ltd.
CN1 YR
Contact Supplier -
HangzhouMeasureLifeTechnologyCo.,LTD
CN1 YR
Contact Supplier